Compare MDXG & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | EGY |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 672.8M | 657.4M |
| IPO Year | 2007 | 1996 |
| Metric | MDXG | EGY |
|---|---|---|
| Price | $3.91 | $6.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $7.00 | ★ $10.20 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 3.88% |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $418,630,000.00 | $359,272,000.00 |
| Revenue This Year | N/A | $24.31 |
| Revenue Next Year | $12.42 | $14.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $3.03 | $3.36 |
| 52 Week High | $7.97 | $6.72 |
| Indicator | MDXG | EGY |
|---|---|---|
| Relative Strength Index (RSI) | 34.21 | 58.67 |
| Support Level | $3.76 | $5.02 |
| Resistance Level | $4.48 | $6.65 |
| Average True Range (ATR) | 0.23 | 0.20 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 26.44 | 71.64 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.